Showing results (2021-2030 of 2,514) with videos related to
Sort By:
Pageof 252
Journal of Clinical Epidemiology|December 12, 2022
Improving grading of recommendations assessment, development, and evaluation evidence tables part 4: a three-arm noninferiority randomized trial demonstrates improved understanding of content in summary of findings tables with a new formatRebecca L Morgan, Juan José Yepes-Nuñez, Joycelyne Ewusie, et al.Infection and Immunity|March 23, 2011
Differential microRNA expression in experimental cerebral and noncerebral malariaFatima El-Assaad, Casper Hempel, Valéry Combes, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 26, 2013
Mitochondrial membrane protein associated neurodegenration: a novel variant of neurodegeneration with brain iron accumulationEva C Schulte, Malte C Claussen, Angela Jochim, et al.Plos One|January 11, 2020
Detection of posttraumatic pneumothorax using electrical impedance tomography-An observer-blinded study in pigs with blunt chest traumaFelix Girrbach, Tobias Landeck, Dominic Schneider, et al.Waste Management (New York, N.Y.)|July 12, 2024
An integral assessment of the impact of diet and manure management on whole-farm greenhouse gas and nitrogen emissions in dairy cattle production systems using process-based modelsLatifa Ouatahar, André Bannink, Jürgen Zentek, et al.Trials|November 26, 2023
Effects of the "ICU Support" team meeting concept on patient-centered and staff-centered outcomes: study protocol for a randomized controlled multicenter studyMarie S Thommes, Martin Klasen, Johannes Bickenbach, et al.Work (Reading, Mass.)|June 4, 2019
Mindfulness meditation for workplace wellness: An evidence mapLara G Hilton, Nell J Marshall, Aneesa Motala, et al.Journal of the American College of Cardiology|December 10, 2003
A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarctionDavid Antoniucci, Alfredo Rodriguez, Albrecht Hempel, et al.Chemical Science|October 27, 2021
Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular propertiesTim Hempel, Katarina Elez, Nadine Krüger, et al.Plos One|February 3, 2022
The development and pilot testing of a behavioral activation-based treatment for depressed mood and multiple health behavior change in patients with recent acute coronary syndromeEmily C Gathright, Katherine Diaz Vickery, Woubeshet Ayenew, et al.Pageof 252